Tag: VLA2001
Valneva: publication on the VLA2001 in the Lancet – 09/06/2022 at 07:43
(CercleFinance.com) – Valneva announces that the medical journal ‘Lancet Infectious Diseases’ has published an article providing a detailed analysis of clinical data from the pivotal phase 3 trial for VLA2001,…
Valneva: new positive results for its anti-Covid 19 VLA2001 vaccine – 08/29/2022 at 07:24
(AOF) – Valneva, a company specializing in vaccines, today announced new positive Phase 3 results for its inactivated and adjuvanted vaccine against Covid-19, VLA2001. Additional data from the company’s pivotal…
Valneva: VLA2001 Becomes First COVID-19 Vaccine to Receive Standard Type Marketing Authorization in Europe
By Claude Leguilloux Published on 06/24/2022 at 6:26 p.m. Photo credit © Valneva …
Valneva is concerned about the future of its European vaccine candidate, VLA2001
By Claude Leguilloux Published on 06/10/2022 at 7:06 p.m. Photo credit © Valneva …